Respiratory Parameter Has A Great Impact in Determining Sepsis Condition in COVID-19 Patients at Saiful Anwar Hospital Malang: Case Report

Authors

  • Caesar Ensang Timuda Pulmonology and Respiratory Medicine Department, Faculty of Medicine, Universitas Brawijaya,/ Saiful Anwar General Hospital, Indonesia
  • Ungky Agus Setyawan Pulmonology and Respiratory Medicine Department, Faculty of Medicine, Universitas Brawijaya,/ Saiful Anwar General Hospital, Indonesia
  • Susanthy Djajalaksana Pulmonology and Respiratory Medicine Department, Faculty of Medicine, Universitas Brawijaya,/ Saiful Anwar General Hospital, Indonesia

DOI:

https://doi.org/10.36408/mhjcm.v7i1A.466

Keywords:

COVID-19, Sepsis, SOFA Score

Abstract

To describe Sequential Organ Failure Assessment (SOFA) Score parameters which have a great impact in the condition of sepsis in Corona Virus Disease-19 (COVID-19) patients and comorbidities that aggravate the patient's condition, we conducted a prospective cohort study in adult patients with sepsis and confirmed COVID-19 cases. We conducted a prospective cohort study in confirmed COVID-19 patients with sepsis who were admitted at Saiful Anwar Hospital Malang at March 10th–April 21st 2020. Diagnosis of sepsis is based on the Surviving Sepsis Campaign-III criteria. We found 6 COVID-19 confirmed patients with sepsis. There is an increased respiratory parameter in SOFA Score in these patients. Therefore, respiratory parameter of the SOFA score has a great impact in determining sepsis condition among confirmed COVID-19 patients.

Keywords: COVID-19, Sepsis, SOFA Score

Downloads

Download data is not yet available.

References

1. Li, Hui. Liu, Liang. Zhang, Dingyu. Jiuyang, Xu. Dai, Huaping. Tang, Nan, et-al. 2020. SARS-COV-2 and viral sepsis: Observation and Hypothesis. China-Japan Friendship Hospital. Beijing. China. Pp 1-4
2. Isbaniah, Fathiyah. Sitompul, Pompini Agustina. Kusumowardhani, Dyani. Manalu, Rudi. Setyawaty, Vivi. Kandun, I Nyoman et al. 2020. Pedoman Pencegahan Pengendalian Coronavirus Disease (COVID-19). Direktorat Jendral Pencegahan dan Pengendalian Penyakit. KEMENKES RI. Jakarta. Indonesia. Pp 11-13
3. Alhazzani, Waleed. Moller, Morten Hylander. Arabi, Yassen M. Loeb, Mark. Ng Gong, Michelle. Fan, Eddy et al. 2020. Surviving Sepsis Campaign: Guidelines on the Management of Criticaly Ill Adults with Coronavirus Disease 2019 (COVID-19). Critical Care Medicine and Wolters Kluwer Health.
4. CDC, 2020. Symptoms of Coronavirus. Cited 13 April 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
5. Li, Ng Yuen. 2020. Imaging of COVID-19 Pneumonia. Parkway Health Radiology
6. Shi, Heshui. Han, Xiaoyu. Jiang, Nanchuan. et al. Radiological Finding From 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Department of Radiology, Wuhan Jinyintan Hospital, Wuhan.China. Pp 425-433
7. Chen Li, Khie. Lau, Chen-Yuen. Chau, Nguyen Van Vinh, et-all. 2018. Utility of SOFA score, management and outcomes of sepsis in Southeast Asia: a multinational multicenter prospective observational study. Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Pp 1-8
8. Burhan, Erlina. Susanto, Agus Dwi. Nasution, Saly A. Ginanjar, Eka. Pitoyo, Ceva W. Susilo, Adityo. et al. 2020. Protokol Tatalaksana COVID-19. Edisi1. PDPI, PERKI, PAPDI, PERDATIN, IDAI. Jakarta Indonesia. Pp 1-10
9. Schiffrin, Ernesto L. Flack, John M. Ito, Sadayoshi. et al. 2020. Hypertension and COVID-19. American Journal of Hypertension, Volume 33, page 373-374
10. Hussain, Akhtar. Bhowmik, Bishwajit. Moreira, Nayla Cristina do Vale. et al. 2020. COVID-19 and Diabetes: Knowledge in Progress. Journal pre-proof in Diabetes Research and Clinical Appearance. International Committee of Medical Journal Editors. Elsevier.
11. Pal, Rimesh. Bhansali, Anil. 2020. COVID-19, Diabetes Mellitus and ACE2: the conundrum. Department of Endocrinology, Post Graduate Institute of Medical Education and Research. Chandigarh. India
12. Kass, David A. Duggal, Priya. Cingolani, Oscar. 2020. Obesity could shift severe COVID-19 disease to younger ages. Johns Hopkins University, Baltimore, USA.
13. Ruan, Qiurong. Yang, Kun. Wang Wenxia. et al. 2020. Clinical Predictors of Mortality Due to COVID-19 based on an Analysis of Data of 150 Patients from Wuhan, China. Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Additional Files

Published

2020-08-28

How to Cite

1.
Timuda CE, Setyawan UA, Djajalaksana S. Respiratory Parameter Has A Great Impact in Determining Sepsis Condition in COVID-19 Patients at Saiful Anwar Hospital Malang: Case Report. Medica Hospitalia J. Clin. Med. [Internet]. 2020 Aug. 28 [cited 2024 Apr. 20];7(1A):176-80. Available from: http://medicahospitalia.rskariadi.co.id/medicahospitalia/index.php/mh/article/view/466

Issue

Vol. 7 No. 1A (2020): Med Hosp; Agustus 2020, Edisi Khusus Covid-19

Section

Case Report

Citation Check

License

Copyright (c) 2020 Medica Hospitalia : Journal of Clinical Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.